GenFleet Therapeutics
Signal active
Organization
Contact Information
Overview
GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize the body's own immune system.
About
Industries
Biotechnology, Health Care, Pharmaceutical, Oncology
Founded
2017
Employees
101-250
Headquarters locations
Asia
Social
N/A
Profile Resume
GenFleet Therapeutics headquartered in Asia, operates in the Biotechnology, Health Care, Pharmaceutical, Oncology sector. The company focuses on Biotechnology and has secured $13.6B in funding across 80 round(s). With a team of 101-250 employees, GenFleet Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - GenFleet Therapeutics, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
5
Investors
6
Lead Investors
0
Total Funding Amount
$169.4M
Details
5
GenFleet Therapeutics has raised a total of $169.4M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Early Stage Venture | 57.7M | ||
| 2018 | Seed | 15.8M | ||
| 2021 | Late Stage Venture | 78.7M | ||
| 2021 | Early Stage Venture |
Investors
GenFleet Therapeutics is funded by 38 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Pan-Lin Capital | - | FUNDING ROUND - Pan-Lin Capital | undefined |
| Linden Asset | - | FUNDING ROUND - Linden Asset | undefined |
| GenFleet Therapeutics | - | FUNDING ROUND - GenFleet Therapeutics | undefined |
| CDH Investments | - | FUNDING ROUND - CDH Investments | undefined |
Recent Activity
There is no recent news or activity for this profile.